new peptide retatrutide GLP-3 (24mg vials) Retatrutide | Research Peptide |

Bottom line: Both formulations produce comparable, clinically meaningful weight lossaround 13-15% on average

Timing matters in CIPN

For individuals who need to avoid the broader effects of growth hormone therapy, whether due to metabolic contraindications, cancer concerns, preference for targeted interventions, or athletic testing considerations, AOD-9604 offers a scientifically-validated alternative

If nausea is persistent, talk to your provider about medication dosage adjustment or adding a short-term anti-nausea medication

Symptoms of glutathione synthetase deficiency may include: Seizures Hampered reaction to speech and physical stimuli Poor coordination Intellectual disability Vulnerability to bacterial infections Low glutathione levels are also associated with a large number of disorders, including some types of cancer and AIDS